Completed PHASE4 INTERVENTIONAL 1-arm NCT01283633

Investigation of the Use of Remote Presence Robots in Delivery of Neuromodulation

Investigation of the Use of Remote Presence Robots in the Administration of Neuromodulation Treatment

Sponsor: Nova Scotia Health Authority

Conditions Complications; Neurostimulator Satisfaction

Updated 5 times since 2017 Last updated: Mar 9, 2012 Started: Feb 28, 2011 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01283633, this PHASE4 trial focuses on Complications; Neurostimulator and Satisfaction and remains completed. Sponsored by Nova Scotia Health Authority, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nova Scotia Health Authority

Data source: Nova Scotia Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halifax, Canada